| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |